AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliminyle-M1 Tablet PR

Diabetac Duo, a dual-action oral medication, belongs to the antidiabetic drug class. This combined formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetac Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Gliminyle-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Gliminyle-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for guidance. Administer Gliminyle-M1 Tablet PR with meals.

Common Side effects of Gliminyle-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminyle-M1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Gliminyle-M1 Tablet PR with a meal.

How Gliminyle-M1 Tablet PR works:

Gliminyle-M1 PR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gliminyle-M1 Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminyle-M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. Your physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Gliminyle-M1 tablets are incompatible; the medication poses a potential risk of infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Gliminyle-M1 Tablet PR requires careful administration in individuals with impaired kidney function. Dosage modification of Gliminyle-M1 Tablet PR might be necessary. Physician consultation is recommended. In patients exhibiting severe kidney disease, Gliminyle-M1 Tablet PR is contraindicated. Routine monitoring of renal function is advised during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle-M1 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, Gliminyle-M1 Tablet PR should typically begin at a low dose; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Gliminyle-M1 Tablet PR :

Should you forget a dose of Gliminyle-M1 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminyle-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminyle-M1 Tablet PR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliminyle-M1 Tablet PR and seek immediate medical attention.
Gliminyle-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It is unsuitable for treating type 1 DM.
Gliminyle-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Gliminyle-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliminyle-M1 Tablet PR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliminyle-M1 Tablet PR and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Gliminyle-M1 Tablet PR
94
MRP 115
18% off